261 related articles for article (PubMed ID: 31836943)
21. Dupilumab strengthens herpes simplex virus type 1-specific immune responses in atopic dermatitis.
Traidl S; Harries L; Kienlin P; Begemann G; Roesner LM; Werfel T
J Allergy Clin Immunol; 2023 Dec; 152(6):1460-1469.e5. PubMed ID: 37660986
[TBL] [Abstract][Full Text] [Related]
22. Systemic herpes simplex virus infection in a child with eczema herpeticum.
Akamatsu M; Kawamura Y; Miura H; Sugimoto E; Okamoto K; Nakajima Y; Kozawa K; Furukawa G; Tanaka M; Kudo K; Yoshikawa T
Pediatr Dermatol; 2023; 40(3):582-583. PubMed ID: 36682743
[TBL] [Abstract][Full Text] [Related]
23. Eczema herpeticum emerging during atopic dermatitis in infancy.
Ertuğrul A; Emeksiz ZŞ; Severcan EU; Özmen S; Bostancı İ
Turk J Pediatr; 2020; 62(3):514-519. PubMed ID: 32558432
[TBL] [Abstract][Full Text] [Related]
24. Eczema herpeticum in children with atopic dermatitis.
Lai YC; Shyur SD; Fu JL
Acta Paediatr Taiwan; 1999; 40(5):325-9. PubMed ID: 10910542
[TBL] [Abstract][Full Text] [Related]
25. High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis -TREATgermany registry analysis.
Traidl S; Heinrich L; Siegels D; Rösner L; Haufe E; Harder I; Abraham S; Ertner K; Kleinheinz A; Schäkel K; Wollenberg A; Effendy I; Quist S; Asmussen A; Wildberger J; Weisshaar E; Wiemers F; Brücher JJ; Weidinger S; Schmitt J; Werfel T;
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1490-1498. PubMed ID: 37814394
[TBL] [Abstract][Full Text] [Related]
26. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.
Kim BE; Bin L; Ye YM; Ramamoorthy P; Leung DYM
J Invest Dermatol; 2013 Dec; 133(12):2678-2685. PubMed ID: 23657503
[TBL] [Abstract][Full Text] [Related]
27. Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum.
Bin L; Li X; Richers B; Streib JE; Hu JW; Taylor P; Leung DYM
J Allergy Clin Immunol; 2018 Jun; 141(6):2085-2093.e1. PubMed ID: 29371118
[TBL] [Abstract][Full Text] [Related]
28. Eczema herpeticum.
Wollenberg A
Chem Immunol Allergy; 2012; 96():89-95. PubMed ID: 22433376
[TBL] [Abstract][Full Text] [Related]
29. Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions.
Takahashi R; Sato Y; Kurata M; Yamazaki Y; Kimishima M; Shiohara T
J Immunol; 2014 Feb; 192(3):969-78. PubMed ID: 24379126
[TBL] [Abstract][Full Text] [Related]
30. Current aspects of innate and adaptive immunity in atopic dermatitis.
Wollenberg A; Klein E
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):35-44. PubMed ID: 18094945
[TBL] [Abstract][Full Text] [Related]
31. History of eczema herpeticum is associated with the inability to induce human β-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis.
Hata TR; Kotol P; Boguniewicz M; Taylor P; Paik A; Jackson M; Nguyen M; Kabigting F; Miller J; Gerber M; Zaccaro D; Armstrong B; Dorschner R; Leung DY; Gallo RL
Br J Dermatol; 2010 Sep; 163(3):659-61. PubMed ID: 20545685
[No Abstract] [Full Text] [Related]
32. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.
Leung DY; Gao PS; Grigoryev DN; Rafaels NM; Streib JE; Howell MD; Taylor PA; Boguniewicz M; Canniff J; Armstrong B; Zaccaro DJ; Schneider LC; Hata TR; Hanifin JM; Beck LA; Weinberg A; Barnes KC
J Allergy Clin Immunol; 2011 Apr; 127(4):965-73.e1-5. PubMed ID: 21458658
[TBL] [Abstract][Full Text] [Related]
33. Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections.
Berdyshev E; Goleva E; Bronova I; Bronoff AS; Streib JE; Vang KA; Richers BN; Taylor P; Beck L; Villarreal M; Johnson K; David G; Slifka MK; Hanifin J; Leung DYM
J Allergy Clin Immunol; 2022 Sep; 150(3):640-648. PubMed ID: 35304160
[TBL] [Abstract][Full Text] [Related]
34. Frequency and Clinical Features Associated With Eczema Herpeticum in Hospitalized Children With Presumed Atopic Dermatitis Skin Infection.
Hemani SA; Edmond MB; Jaggi P; Cooley A
Pediatr Infect Dis J; 2020 Apr; 39(4):263-266. PubMed ID: 31764378
[TBL] [Abstract][Full Text] [Related]
35. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.
Bin L; Edwards MG; Heiser R; Streib JE; Richers B; Hall CF; Leung DY
J Allergy Clin Immunol; 2014 Oct; 134(4):848-55. PubMed ID: 25159465
[TBL] [Abstract][Full Text] [Related]
37. Eczema herpeticum subsequent to septic shock in early pregnancy: a first case report.
Furuya K; Takemoto Y; Kurahashi H; Hayashida H; Fujiwara S; Yamashita S; Chang Y; Tsubouchi H; Shikado K; Ogita K
BMC Infect Dis; 2021 Dec; 21(1):1247. PubMed ID: 34906081
[TBL] [Abstract][Full Text] [Related]
38. Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.
Oyoshi MK; Beaupré J; Venturelli N; Lewis CN; Iwakura Y; Geha RS
J Allergy Clin Immunol; 2015 Jun; 135(6):1511-8.e6. PubMed ID: 25649082
[TBL] [Abstract][Full Text] [Related]
39. Herpesviruses and the microbiome.
Dreyfus DH
J Allergy Clin Immunol; 2013 Dec; 132(6):1278-86. PubMed ID: 23611298
[TBL] [Abstract][Full Text] [Related]
40. Atopic dermatitis.
Peters N; Peters AT
Allergy Asthma Proc; 2019 Nov; 40(6):433-436. PubMed ID: 31690388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
